Previous 10 | Next 10 |
2024-02-20 16:28:02 ET More on NeoGenomics NeoGenomics: Progress, But A New Uncertainty NeoGenomics Q4 2023 Earnings Preview NeoGenomics ruling seen having limited impact on estimates, Needham says Seeking Alpha’s Quant Rating on NeoGenomics Hi...
Fourth Quarter Revenue Increased 12% to $156 million; Full Year Revenue Increased 16% to $592 million NeoGenomics, Inc. (Nasdaq: NEO) (the “Company”) , a leading provider of oncology testing and global contract research services, today announced fourth quarter and fu...
Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...
2024-02-19 17:35:09 ET Major earnings expected after the bell on Tuesday include: Realty Income Corporation ( O ) Teladoc Health ( TDOC ) Palo Alto Networks ( PANW ) Chesapeake Energy Corporation ( CHK ) SolarEdge Technologies ( SEDG ) Read ...
2024-02-18 17:35:00 ET More on NeoGenomics NeoGenomics: Progress, But A New Uncertainty NeoGenomics ruling seen having limited impact on estimates, Needham says Natera wins court order barring NeoGenomics from selling RaDaR assay (update) Seeking Alpha’...
2024-02-04 10:07:53 ET Summary Today, we revisit NeoGenomics, a cancer genetics testing company,. The company is making progress around delivering sales growth and reducing losses. The company has a potential new problem on the litigation front, however. What's ahead for...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that the Company has signed the Working with Cancer Pledge . By taking the pledge, NeoGenomics demonstrates its commitment to supporting team members living with or caring for a loved one with cancer...
2024-01-31 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its fourth quarter and full year 2023 financial results on Tuesday, February 20, 2024. Company management will host a webcast and conference call that day at 4:30 p.m. Eastern Time ...
2024-01-10 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
NeoGenomics Inc. Company Name:
NEO Stock Symbol:
NASDAQ Market:
In the latest cryptocurrency market update, Neo (NEO) has significantly outperformed Dogwifhat (WIF) with a price surge of over 35%. What Happened:...
2024-04-13 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its first quarter 2024 financial results on Tuesday, April 30, 2024. Company management will host a webcast and conference call that morning at 8:30 a.m. Eastern Time to discuss fin...